Cited by 54Blood transfusion and managementTrauma, Hemostasis, Coagulopathy, ResuscitationMaternal and fetal healthcare

The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia

Open access
Matsunaga, Shigetaka, Takai, Yasushi, Nakamura, Eishin, Era, Sumiko, Ono, Yoshihisa, Yamamoto, Koji, Maeda, Hiroo, Seki, Hiroyuki·2017·Scientific Reports

Abstract

Massive obstetric haemorrhage remains a major cause of maternal death attributable to hypofibrinogenaemia. Transfusion of large volumes of fresh frozen plasma (FFP) is required to normalise fibrinogen levels. We compared the efficacy of FFP (F group) with that of FFP plus fibrinogen concentrate (F + F group) in massive obstetric haemorrhage. In this retrospective study, we compared the medical charts (2004-2016) of 137 patients with <150 mg/dl fibrinogen treated with F + F (n = 47; after August 2009) or F (n = 56; before August 2009). Although fibrinogen concentrate was only administered in severe cases, the FFP/red blood cell concentrate (RCC) ratio was significantly lower in the F + F group than in the F group. A sub-group analysis of cases requiring ≥18 RCC units showed that the F + F group received significantly less FFP than the F group (40.2 ± 19.6 versus 53.4 ± 18.5 units; P = 0.047) and showed significantly less pulmonary oedema (24.0% vs 57.1%; P < 0.05) in the absence of any significant differences in pre-transfusion coagulation, estimated blood loss, or RCC transfusion volume. Administration of fibrinogen concentrate increased the rate of fibrinogen supplementation five-fold and reduced FFP dosage, the FFP/RCC ratio, and the incidence of pulmonary oedema.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep46749

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Observational studies suggest that administration of fibrinogen concentrate may reduce blood loss in hemorrhage-associated hypofibrinogenemia associated with abruption.

    “Observational studies suggest that administration of fibrinogen concentrate may result in reduced blood loss in hemorrhage associated hypofibrinogenemia associated with abruption (102, 103).”

    From Placental abruption at near-term and term gestations: Pathophysiology, epidemiology, diagnosis, and management (2023) · cites this paper as [102]

    The Discussion suggests fibrinogen concentrate could minimise blood loss in early-stage placental abruption, supporting the claim’s tentative wording. But the Results report no significant difference in estimated blood loss for that subgroup; the paper does not show a measured reduction or extend the suggestion beyond early-stage cases. No page numbers are available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Matsunaga, S., Takai, Y., Nakamura, E., Era, S., Ono, Y., Yamamoto, K., Maeda, H., & Seki, H.
Affiliations
Saitama Medical Center, Saitama Medical University (JP)
Corresponding author
Matsunaga, Shigetaka
Venue
Scientific Reports
Published
2017-04-24
Volume
7
Issue
1
Pages
46749-46749
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2609151975
Cited by
54
References
33
Citations by year
2026: 3 · 2025: 6 · 2024: 9 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 4 · 2019: 10 · 2018: 5 · 2017: 1
FWCI
3.69
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Saitama Medical University
  • Japan Society for the Promotion of Science (26462499)
Topics
  • Health Sciences › Medicine › Biochemistry › Blood transfusion and management
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
Keywords
fibrinogen concentrate, hypofibrinogenemia, fresh frozen plasma, packed red blood cells, pulmonary edema, maternal mortality, blood transfusion, fibrinogen supplementation
MeSH terms
Adult, Female, Fibrinogen, Hemorrhage, Humans, Pregnancy, Pregnancy Complications, Retrospective Studies, Treatment Outcome, Coagulation Protein Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review